Edwin M Kania Jr's Net Worth

$5.73 Billion

Who is Edwin M Kania Jr?

Edwin M Kania Jr has an estimated net worth of $5.73 Billion. This is based on reported shares across multiple companies, which include Moderna, Inc., Kaleido Biosciences, Inc., TETRAPHASE PHARMACEUTICALS INC, AGIOS PHARMACEUTICALS INC, BG Medicine, Inc., BIND Therapeutics, Inc, Receptos, Inc., Seres Therapeutics, Inc., Editas Medicine, Inc., TransMedics Group, Inc., Quanterix Corp, CONCERT PHARMACEUTICALS, INC., SELECTA BIOSCIENCES INC, Rubius Therapeutics, Inc., Syros Pharmaceuticals, Inc., Eleven Biotherapeutics, Inc., T2 Biosystems, Inc., Axcella Health Inc., Evelo Biosciences, Inc., HELICOS BIOSCIENCES CORP, ACCELERON PHARMA INC, ASPECT MEDICAL SYSTEMS INC, and EXACT SCIENCES CORP.

SEC CIK

Edwin M Kania Jr's CIK is 0001255927

Past Insider Trading and Trends

2014 was Edwin M Kania Jr's most active year for acquiring shares with 41 total transactions. Edwin M Kania Jr's most active month to acquire stocks was the month of November. 2014 was Edwin M Kania Jr's most active year for disposing of shares, totalling 74 transactions. Edwin M Kania Jr's most active month to dispose stocks was the month of November. 2023 saw Edwin M Kania Jr paying a total of $19,339,965.52 for 245,586 shares, this is the most they've acquired in one year. In 2014 Edwin M Kania Jr cashed out on 31,853,123 shares for a total of $43,535,243.88, their largest year based on trade value.